Search details
1.
Costs associated with invasive Scedosporium and Lomentospora prolificans infections: a case-control study.
J Antimicrob Chemother
; 79(1): 46-54, 2024 Jan 03.
Article
in English
| MEDLINE | ID: mdl-37944018
2.
Diverse effects of interferon alpha on the establishment and reversal of HIV latency.
PLoS Pathog
; 16(2): e1008151, 2020 02.
Article
in English
| MEDLINE | ID: mdl-32109259
3.
Impact of Anti-PD-1 and Anti-CTLA-4 on the Human Immunodeficiency Virus (HIV) Reservoir in People Living With HIV With Cancer on Antiretroviral Therapy: The AIDS Malignancy Consortium 095 Study.
Clin Infect Dis
; 73(7): e1973-e1981, 2021 10 05.
Article
in English
| MEDLINE | ID: mdl-33677480
4.
HIV integration and the establishment of latency in CCL19-treated resting CD4(+) T cells require activation of NF-κB.
Retrovirology
; 13(1): 49, 2016 07 26.
Article
in English
| MEDLINE | ID: mdl-27459960
5.
Inhibition of telomerase activity by human immunodeficiency virus (HIV) nucleos(t)ide reverse transcriptase inhibitors: a potential factor contributing to HIV-associated accelerated aging.
J Infect Dis
; 207(7): 1157-65, 2013 Apr.
Article
in English
| MEDLINE | ID: mdl-23303810
6.
Predictors of liver disease progression in people living with HIV-HBV co-infection on antiretroviral therapy.
EBioMedicine
; 102: 105054, 2024 Apr.
Article
in English
| MEDLINE | ID: mdl-38518655
7.
HIV DNA persists in hepatocytes in people with HIV-hepatitis B co-infection on antiretroviral therapy.
EBioMedicine
; 87: 104391, 2023 Jan.
Article
in English
| MEDLINE | ID: mdl-36502576
8.
Prospective comprehensive profiling of immune responses to COVID-19 vaccination in patients on zanubrutinib therapy.
EJHaem
; 4(1): 216-220, 2023 Feb.
Article
in English
| MEDLINE | ID: mdl-36819189
9.
Neurotoxicity with high-dose disulfiram and vorinostat used for HIV latency reversal.
AIDS
; 36(1): 75-82, 2022 01 01.
Article
in English
| MEDLINE | ID: mdl-34586085
10.
The impact of immune checkpoint therapy on the latent reservoir in HIV-infected individuals with cancer on antiretroviral therapy.
AIDS
; 35(10): 1631-1636, 2021 08 01.
Article
in English
| MEDLINE | ID: mdl-33859108
11.
A randomized trial of vorinostat with treatment interruption after initiating antiretroviral therapy during acute HIV-1 infection.
J Virus Erad
; 6(3): 100004, 2020 Sep.
Article
in English
| MEDLINE | ID: mdl-33251022
12.
The effect of antiretroviral intensification with dolutegravir on residual virus replication in HIV-infected individuals: a randomised, placebo-controlled, double-blind trial.
Lancet HIV
; 5(5): e221-e230, 2018 05.
Article
in English
| MEDLINE | ID: mdl-29643011
13.
Variation in cell-associated unspliced HIV RNA on antiretroviral therapy is associated with the circadian regulator brain-and-muscle-ARNT-like-1.
AIDS
; 32(15): 2119-2128, 2018 09 24.
Article
in English
| MEDLINE | ID: mdl-30005017
14.
No adverse safety or virological changes 2 years following vorinostat in HIV-infected individuals on antiretroviral therapy.
AIDS
; 31(8): 1137-1141, 2017 05 15.
Article
in English
| MEDLINE | ID: mdl-28301423
15.
No difference in the rate of change in telomere length or telomerase activity in HIV-infected patients after three years of darunavir/ritonavir with and without nucleoside analogues in the MONET trial.
PLoS One
; 9(11): e109718, 2014.
Article
in English
| MEDLINE | ID: mdl-25368992
16.
Post-treatment control in an adult with perinatally acquired HIV following cessation of antiretroviral therapy.
AIDS
; 31(9): 1344-1346, 2017 06 01.
Article
in English
| MEDLINE | ID: mdl-28492397
Results
1 -
16
de 16
1
Next >
>>